A Case of Platinum-Sensitive Epithelial Ovarian Cancer

Video

A Case of Platinum-Sensitive Epithelial Ovarian Cancer

A 49-Year-Old Woman with Platinum-Sensitive Epithelial Ovarian Cancer and GermlineBRCA1Mutation

March 2013

  • A 49-year-old African American woman presented to her primary care physician complaining of abdominal bloating
  • PMH: chronic HBV infection, mild HTN
  • FH: mother died of breast cancer at age 59, cousin on mother’s side died of ovarian cancer at age 65
  • CT, ascites and bilateral 8-cm adnexal masses
  • CA 125, 285 U/mL
  • She underwent exploratory laparotomy followed by omentectomy, bilateral salpingo-oophorectomy, pelvic lymph node dissection, appendectomy, and resection of pelvic nodules
    • No gross residual disease (R0)
    • Germline molecular testing showed aBRCA1alteration
  • Pathology: high grade epithelial ovarian cancer involving omentum, both ovaries, and 3 micro-metastatic lymph nodes
  • She was treated with IV/IP paclitaxel/cisplatin; after completion, CA 125, 14.2, clinically NED

September 2015

  • 18 months later, on routine follow up, CA 125, 203 U/mL
  • Lymph node disease and carcinomatosis on imaging  
  • She was treated with gemcitabine/carboplatin for 6 cycles
    • CA 125, 11.3; clinically NED
  • The patient was started on rucaparib maintenance therapy while enrolled on a clinical trial
  • After 2 cycles of therapy, the patient’s live enzymes rose transiently and then returned to normal
    • AST, 127 U/L
    • ALT, 142 U/L
    • Creatinine, 1.5 mg/d            

November 2017

  • The patient complained of worsening fatigue and bloating
  • CA 125, 1004 U/mL
Recent Videos
Jamie L. Koprivnikar, MD, an expert on MDS
Jamie L. Koprivnikar, MD, an expert on MDS
Jamie L. Koprivnikar, MD, an expert on MDS
Jamie L. Koprivnikar, MD, an expert on MDS
Jamie L. Koprivnikar, MD, an expert on MDS
Jamie L. Koprivnikar, MD, an expert on MDS
Jamie L. Koprivnikar, MD, an expert on MDS
Jamie L. Koprivnikar, MD, an expert on MDS
Solly Chedid, MD, an expert on MDS
Solly Chedid, MD, an expert on MDS
Related Content